CCDC3 and fatty liver disease: Surprisingly, the transgenic (TG) mice ubiquitously overexpressing CCDC3 driven by a cytomegalovirus promoter exhibited relieved glucose intolerance, insulin insensitivity, and hepatic steatosis.